Fall Clinical Dermatology Conference for PAs & NPs

Catch up on coverage from the last day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Lockshin shared his approach to continuing biologic therapies into pregnancy with informed timing adjustments.

Jason Hawkes, MD, MS, breaks down boxed warning pros and cons and research addressing several boxed warnings.

The country's only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.

James Song, MD, addressed current challenges in the AD treatment landscape and compared biologics.

Jason Hawkes, MD, MS, gives an overview of what clinicians need to know today about this rare condition.

Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.

Catch up on coverage from the second day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

James Song, MD, discusses the current treatment landscape, genetic and immunological influences, and the role of oral minoxidil in alopecia areata.

Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies to enhance patient quality of life.

The trial results indicated 3 significant improvements across all AHFD subtypes with dupilumab treatment compared to placebo.

Catch up on coverage from the first day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

Improvements persisted through the 12-week post-treatment follow-up, indicating sustained efficacy even after discontinuation of dupilumab.

Four leaders in HS treatment and care put a spotlight on the latest clinical trial data and treatment techniques.

Terry Arnold, PA-C, shared his journey and advice for PAs and NPs looking to transition out of a clinical practice.

Significant improvements were observed in EASI scores across all anatomical regions, regardless of patient age or specific body region.

Dermatology Times will bring clinical insights from leading experts in numerous dermatology specialties.

Whether you are attending in-person or looking to Dermatology Times coverage, let us know which topics interest you most.

Dermatology Times is counting down to the annual Fall Clinical conference in Las Vegas, Nevada, with our top 5 headlines and highlights from this year's PA and NP summer conference.

Dermatology Times had the opportunity to speak with numerous leading KOLs in the industry, live and virtually, at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Cameron guided attendees at the Fall Clinical Dermatology Conference for PAs and NPs on his treatment considerations for psoriasis and pigmentary disorders during his 2 sessions.

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Stein Gold reviewed biologics and JAK inhibitors for AD at Fall Clinical for PAs and NPs, as well as topical and oral agents for tough acne.